Evidence map›Paper›PMID 36479502›Full record

ReviewJournal of preventive medicine and hygiene2022

Dietary supplements for lipedema.

Gabriele Bonetti, Karen L Herbst, Kristjana Dhuli, Aysha Karim Kiani, Serena Michelini, Silvia Michelini, Maria Rachele Ceccarini, Sandro Michelini, Maurizio Ricci, Marina Cestari and 5 more

Open access · greenAbstract readReview
In one paragraph

Review in Journal of preventive medicine and hygiene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Serum Metabolomic Profiling of Patients with Lipedema.International journal of molecular sciences · 2023
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Gabriele BonettiMAGI'S LAB, Rovereto (TN), Italy.
Karen L HerbstTotal Lipedema Care, Beverly Hills California and Tucson Arizona, USA.
Kristjana DhuliMAGI'S LAB, Rovereto (TN), Italy.
Aysha Karim KianiMAGI EUREGIO, Bolzano, Italy.
Serena MicheliniUnit of Physical Medicine, Sapienza University of Rome, Rome, Italy.
Silvia MicheliniNeurosurgery, University of Tor Vergata, Rome, Italy.
Maria Rachele CeccariniDepartment of Pharmaceutical Sciences; University of Perugia, Perugia.
Sandro MicheliniVascular Diagnostics and Rehabilitation Service, Marino Hospital, ASL Roma 6, Marino, Italy.
Maurizio RicciDivision of Rehabilitation Medicine, Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Italy.
Marina CestariStudy Centre Pianeta Linfedema, Terni, Italy.
Michela CodiniDepartment of Pharmaceutical Sciences; University of Perugia, Perugia.
Tommaso BeccariDepartment of Pharmaceutical Sciences; University of Perugia, Perugia.
Francesco BellinatoSection of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
Paolo GisondiSection of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
Matteo BertelliMAGI'S LAB, Rovereto (TN), Italy.
University of Verona · ITAzienda Ospedaliero Universitaria Ospedali Riuniti · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipedema is a chronic disease that mostly manifests in females as the abnormal distribution of subcutaneous adipose connective tissue, usually coupled with bruising, pain, and edema. Lipedema molecular pathophysiology is currently not clear, but several studies suggest that genetics and hormonal imbalance participate in lipedema pathogenesis. Women with lipedema present in some cases with elevated body mass index, and the appearance of obesity in addition to lipedema, where the obesity can cause serious health issues as in lipedema-free individuals with obesity, such as diabetes and cardiovascular disorders. Unlike obesity, lipedema tissue does not respond well to diet or physical exercise alone. Therefore, in this review we discuss the effect of various dietary supplements that, along with diet and physical exercise, cause fat burning and weight loss, and which could potentially be important in the treatment of lipedema. Indeed, an effective fat burner should convert stored fats into energy, mobilize and break down triglycerides in adipocytes, boost metabolism and inhibit lipogenesis. Common ingredients of fat burning supplements are green tea, caffeine, chromium, carnitine, and conjugated linoleic acid. The use of fat burners could act synergistically with a healthy diet and physical exercise for decreasing adipose tissue deposition in patients with lipedema and resolve related health issues. The effects of fat burners in human studies are sometimes contradictory, and further studies should test their effectiveness in treating lipedema.

Indexed as

Dietary SupplementsExerciseFemaleHumansObesityDietary supplementsFat burnersFat burning supplementsWeight loss in lipedema

Identifiers

PMID36479502
PMCPMC9710418
OpenAlexW4311575486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.